Artificial intelligence-based evaluation of prognostic benefits from immunotherapy plus targeted therapy with or without radiotherapy or TACE in advanced hepatocellular carcinoma
{{output}}
Background: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, and the prognosis of advanced disease is still poor. Immunotherapy plus targeted therapy has reshaped systemic treatment; h... ...
